By using this albumin-binding technology, the peptides plasma half-life is stretched significantly
In most cancers, these signaling pathways are overactivated, caused by mutation, overexpression, etc
The publication reported body-weight and glycemic endpoints that were qualitatively consistent with REDEFINE 1, with the combination arm favored over placebo on the reported measures
Regulatory Status FDA, WADA anti-doping, and compounding status provided for research context
Further, to avoid the worsening of disease activity or quality of life following the drug tapering, a close monitoring of these patients should be conducted, i.e., by employing biomarkers of inflammation, such as fecal calprotectin in the case of IBD to predict a disease relapse after anti-TNF- withdrawal or de-escalation
Lloyd Camper, MD, MPH, physician at Cenegenics Miami, thinks thats exactly backwards